Probable RBD and association with neurodegenerative disease markers: A population‐based study
Philipp Mahlknecht(University College London), Birgit Högl(Innsbruck Medical University), Heike Stockner(Innsbruck Medical University), Gregor Rungger(Innsbruck Medical University), Johann Willeit(Innsbruck Medical University), Stefan Kiechl(Innsbruck Medical University), Atbin Djamshidian(Innsbruck Medical University), Werner Poewe(Innsbruck Medical University), Michael Nocker(Innsbruck Medical University), Verena Rastner(Innsbruck Medical University), Klaus Seppi(Innsbruck Medical University), Arno Gasperi(Krankenhaus Bruneck), Birgit Frauscher(Montreal Neurological Institute and Hospital), Michaela Defrancesco(Innsbruck Medical University)
Cited by 104
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
|Circulation Research|2010|1.5k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k